title: Lead remediation and changes in human lead exposure: some physiological and biokinetic dimensions.
abstract: This paper presents a qualitative and quantitative analysis of the various aspects of lead remediation effectiveness with particular reference to human health risk assessment. One of the key elements of lead remediation efforts at such sites as those under the Superfund program deals with populations at elevated exposure and toxicity risk in the proximity of, or at, the site of remediation, especially remediation workers, workers at other tasks on sites that were remediated down to some action level of lead concentration in soils, and groups at risk in nearby communities. A second element has to do with how one measures or models lead exposure changes with special reference to baseline and post-remediation conditions. Various biomarkers of lead exposure can be employed, but their use requires detailed knowledge of what results using each means. The most commonly used approach is measurement of blood lead (Pb-B). Recognized limitations in the use of Pb-B has led to the use of predictive Pb exposure models, which are less vulnerable to the many behavioral, physiological, and environmental parameters that can distort isolated or 'single shot' Pb-B testings. A third aspect covered in this paper presents various physiological factors that affect the methods by which one evaluates Pb remediation effectiveness. Finally, this article offers an integrated look at how lead remediation actions directed at one lead source or pathway affect the total lead exposure picture for human populations at elevated lead exposure and toxicity risk.
authors.affiliation: PB Associates, 714 Ninth Street, Ste 204, Durham, NC 27705, USA. pandbmushak@cs.com
authors.forename: Paul
authors.initials: P
authors.lastname: Mushak
mesh_terms: D015415:Biomarkers / Q000032:analysis; D004781:Environmental Exposure; D004787:Environmental Pollution / Q000517:prevention & control*; D006256:Hazardous Waste; D006801:Humans; D007854:Lead / Q000009:adverse effects* / Q000302:isolation & purification / Q000493:pharmacokinetics*; D007855:Lead Poisoning / Q000175:diagnosis*; D011634:Public Health; D018570:Risk Assessment
chemical_list: D015415:Biomarkers; D006256:Hazardous Waste; D007854:Lead